抗NMDA受體腦炎合併重積型癲癇：一病例報告

Anti-NMDA Receptor Encephalitis with Status Epilepticus: A Case Report

陳蓉芳(Jung-Fang Chen) ； 沈修年(Hsiu-Nien Shen) ； 楊浚銘(Chin-Ming Yang) ； 蘇慧真(Hui-Chen Su)

《台灣醫學》 22卷5期 (2018/09) Pp. 482-485

https://doi.org/10.6320/FJM.201809_22(5).0003

摘要

抗NMDA受體腦炎是一種自體免疫疾病，症狀包括行為異常記憶障礙、運動障礙、精神症狀、癲癇、呼吸衰竭等。此疾病與女性卵巢畸胎瘤相關，該疾病最重要的治療關鍵是早期診斷和早期治療。治療以早期切除腫瘤，並積極使用免疫療法，可提升治療結果。本案例為26歲女性無過去病史，近兩日有發燒、局部癲癇、小便失禁、精神症狀，且有呼吸短促等情形。住院期間個案出現臉部抽搐及重積型癲癇；經使用免疫抑制劑、高劑量抗癲癇藥物、血漿置換術及切除腫瘤後，症狀明顯進步。

關鍵字

抗NMDA受體腦炎 ； 重積型癲癇

並列摘要

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune disorder. Clinical presentation includes behavior, memory, motor dysfunction, psychiatric symptoms, seizure and hypoventilation. The disorder has been previously associated with ovarian teratoma which particularly females. Confirmation of anti-NMDAR encephalitis is the key to early diagnosis and prompt treatment, which may alter the course of the disease. Early tumor removal and aggressive immunotherapy is the key to improved clinical outcomes. We present the case of a 26-year-old female, with no known prior medical problems. Two days after admission, she developed fever, focal seizure, urine incontinence, psychiatric symptoms, and dyspnea. On admission to our hospital, she presented with involuntary orofacial movements and refractory status epilepticus. The patient's status epilepticus and psychotic symptoms, markedly improved following immunotherapy, high dose anti-epilepitic drugs, plasma exchange and removal teratoma.

並列關鍵字

Anti-N-methyl-D-aspartate receptor encephalitis ； status epilepticus

參考文獻

Dalmau J, Lancaster E, Martinez-Hernandez E, et al: Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011;10:63-74."

Ryan SA, Costello DJ, Cassidy EM, et al: Anti-NMDA receptor encephalitis: a cause of acute psychosis and catatonia. J Psychiatr Pract 2013;19:157-61."

Granerod J, Ambrose HE, Davies NW, et al: Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based rospective study. Lancet Infect Dis 2010;10:835-44."

Dalmau J, Gleichman AJ, Hughes EG, et al: Anti-NMDA-receptor-encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091-98."

Lisman JE, Coyle JT, Green RW, et al: Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci 2008;31:234-42."